194 related articles for article (PubMed ID: 24375894)
21. Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC.
Low RN; Barone RM; Lee MJ
Ann Surg Oncol; 2013 Apr; 20(4):1074-81. PubMed ID: 23456382
[TBL] [Abstract][Full Text] [Related]
22. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
[TBL] [Abstract][Full Text] [Related]
23. [Results of close testicular tumor after-care].
Erpenbach K; Derschum W; Reis M; von Vietsch H
Urologe A; 1990 Mar; 29(2):102-7; discussion 107-9. PubMed ID: 2158683
[TBL] [Abstract][Full Text] [Related]
24. Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology.
Takami H; Graffeo CS; Perry A; Giannini C; Nakazato Y; Saito N; Matsutani M; Nishikawa R; Daniels DJ; Ichimura K
Brain Tumor Pathol; 2023 Apr; 40(2):124-132. PubMed ID: 36995447
[TBL] [Abstract][Full Text] [Related]
25. Serum tumour markers in gynaecological cancers.
Aggarwal P; Kehoe S
Maturitas; 2010 Sep; 67(1):46-53. PubMed ID: 20510555
[TBL] [Abstract][Full Text] [Related]
26. Management of germ cell tumors in children: approaches to cure.
Göbel U; Calaminus G; Schneider DT; Schmidt P; Haas RJ;
Onkologie; 2002 Feb; 25(1):14-22. PubMed ID: 11893878
[TBL] [Abstract][Full Text] [Related]
27. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract][Full Text] [Related]
28. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
[TBL] [Abstract][Full Text] [Related]
29. Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Vogel H; Yeom KW; Fisher PG; Partap S
J Neurooncol; 2014 Feb; 116(3):617-23. PubMed ID: 24401959
[TBL] [Abstract][Full Text] [Related]
30. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
31. An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors.
Hu M; Guan H; Lau CC; Terashima K; Jin Z; Cui L; Wang Y; Li G; Yao Y; Guo Y; Li YM; Zhong D; Xiao J; Wan X; Lian X; Feng F; Ren H; Zhao Y; Cheng X; Gu F
Eur J Med Res; 2016 Mar; 21():10. PubMed ID: 26968839
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
[TBL] [Abstract][Full Text] [Related]
33. Potential role of ventricular tumor markers in CNS germ cell tumors.
Legault G; Allen JC
Pediatr Blood Cancer; 2013 Oct; 60(10):1647-50. PubMed ID: 23788492
[TBL] [Abstract][Full Text] [Related]
34. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.
Kang CH; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Feb; 85(2):379-84. PubMed ID: 18222229
[TBL] [Abstract][Full Text] [Related]
35. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
[TBL] [Abstract][Full Text] [Related]
36. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
[TBL] [Abstract][Full Text] [Related]
37. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
38. Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.
Fonseca A; Xia C; Lorenzo AJ; Krailo M; Olson TA; Pashankar F; Malogolowkin MH; Amatruda JF; Billmire DF; Rodriguez-Galindo C; Frazier AL; Shaikh F
J Clin Oncol; 2019 Feb; 37(5):396-402. PubMed ID: 30576269
[TBL] [Abstract][Full Text] [Related]
39. Tumor markers at the time of recurrence in patients with germ cell tumors.
Trigo JM; Tabernero JM; Paz-Ares L; García-Llano JL; Mora J; Lianes P; Esteban E; Salazar R; López-López JJ; Cortés-Funes H
Cancer; 2000 Jan; 88(1):162-8. PubMed ID: 10618619
[TBL] [Abstract][Full Text] [Related]
40. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
Raghavan D; Boyer M
Prog Clin Biol Res; 1990; 350():309-18. PubMed ID: 2166960
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
